FEDERATED HERMES, INC.

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA

Position in PTCT

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$15,391,655

+$6,841,143 QoQ

Shares Held

225,916

+100.7% QoQ

Ownership

0.272%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FEDERATED HERMES, INC. holds $2,358,506,481 across 147 Biotechnology names. PTCT ranks #37 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	687,816	$227,577,679
2	REGN	Regeneron Pharmaceuticals, Inc.	254,946	$196,981,475
3	RYTM	Rhythm Pharmaceuticals, Inc.	1,286,303	$111,869,771
4	MRNA	Moderna, Inc.	1,977,079	$100,435,613
5	IDYA	IDEAYA Biosciences, Inc.	2,987,107	$99,530,405
6	INSM	INSMED Inc	538,257	$88,015,784
7	CNTA	Centessa Pharmaceuticals plc	2,049,439	$81,403,717
8	EYPT	EyePoint, Inc.	5,669,589	$73,081,000

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,391,655	225,916	+100.7%	Shares	Defined	2026-05-11
2025-12-31	$8,550,512	112,566	+659.8%	Shares	Defined	2026-02-12
2025-09-30	$909,257	14,816	-39.0%	Shares	Defined	2025-11-03
2025-06-30	$1,186,030	24,284	-67.8%	Shares	Defined	2025-08-13
2025-03-31	$3,839,580	75,345	+57.5%	Shares	Defined	2025-05-08
2024-12-31	$2,158,955	47,828	+6433.9%	Shares	Defined	2025-02-13
2023-06-30	$29,770	732	-90.8%	Shares	Defined	2023-08-14
2023-03-31	$387,374	7,997	-89.0%	Shares	Defined	2023-05-08
2022-09-30	$3,638,345	72,477	+329340.9%	Shares	Defined	2022-11-14
2021-03-31	$1,041	22	-100.0%	Shares	Defined	2021-05-13
2020-12-31	$2,771,921	45,419	+3613.7%	Shares	Defined	2021-02-12
2020-03-31	$54,558	1,223	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.